Researchers from the National Institutes of Health are using large language models to develop an artificial intelligence framework to streamline the clinical trial matching process and more quickly link potential volunteers to relevant trials…
Continue Reading
What You Should Know:
– Cedars-Sinai Cancer is taking a major step towards addressing health disparities by participating in the largest-ever national study focused on cancer risk factors in Asian Americans.
– The initiative, funded by…
Continue Reading
What You Should Know:
– Reimagine Care, the nation’s leading provider of on-demand cancer care, and Moffitt Cancer Center, the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida and host of the CancerX initiative, announce today a…
Continue Reading
Once a cancer diagnosis is confirmed, a patient’s life is not only altered but there is a lot to learn as they make care decisions.”For cancer survivors and those managing a recent diagnosis, having…
Continue Reading
What You Should Know:
– A glimmer of hope emerged today for rectal cancer patients as a collaborative effort between Case Western Reserve University (CWRU), Cleveland Clinic, and University Hospitals (UH) received a $2.78 million…
Continue Reading
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have developed an artificial intelligence tool that predicts whether a patient will respond to cancer treatment drugs using individual…
Continue Reading
What You Should Know:
– Tempus, a leader in artificial intelligence and precision medicine, announced a groundbreaking data contribution to the National Cancer Institute (NCI) today.
– The first-of-its-kind contribution will significantly enhance the NCI’s planned…
Continue Reading
Philochem and Blue Earth Diagnostics celebrate a pivotal advancement in their collaboration, initiating a Phase 1 Clinical Trial with 68Ga-OncoFAP for imaging solid tumors. This partnership aims to explore OncoFAP, a specialized ligand targeting…
Continue Reading
Elekta has won a tender to supply several Harmony linear accelerators (linacs) to Ukraine, aiming to alleviate the country’s cancer treatment shortage. These modern radiation therapy devices will be operational by 2024, enhancing cancer…
Continue Reading
By Sara Heath
September 25, 2023 – Fewer than one in five oncology practices screen family caregivers for signs of emotional distress despite the significant burden these informal caregivers carry during a loved one’s cancer journey,…
Continue Reading
